Art. 123 Directive (EU) 2001/83

In forcesince 16 Nov 2012cited 4×
1.

Each Member State shall take all the appropriate measures to ensure that decisions authorizing marketing, refusing or revoking a marketing authorization, cancelling a decision refusing or revoking a marketing authorization, prohibiting supply, or withdrawing a product from the market, together with the reasons on which such decisions are based, are brought to the attention of the Agency forthwith.

2.

The marketing authorisation holder shall be obliged to notify the Member States concerned forthwith of any action taken by the holder to suspend the marketing of a medicinal product, to withdraw a medicinal product from the market, to request the withdrawal of a marketing authorisation or not to apply for the renewal of a marketing authorisation, together with the reasons for such action. The marketing authorisation holder shall in particular declare if such action is based on any of the grounds set out in Article 116 or Article 117(1).

2a.

The marketing authorisation holder shall also make the notification pursuant to paragraph 2 of this Article in cases where the action is taken in a third country and where such action is based on any of the grounds set out in Article 116 or Article 117(1).

2b.

The marketing authorisation holder shall furthermore notify the Agency where the action referred to in paragraph 2 or 2a of this Article is based on any of the grounds referred to in Article 116 or Article 117(1).

2c.

The Agency shall forward notifications received in accordance with paragraph 2b to all Member States without undue delay.

3.

Member States shall ensure that appropriate information about action taken pursuant to paragraphs 1 and 2 which may affect the protection of public health in third countries is forthwith brought to the attention of the World Health Organization, with a copy to the Agency.

4.

Each year, the Agency shall make public a list of the medicinal products for which marketing authorisations have been refused, revoked or suspended in the Union, whose supply has been prohibited or which have been withdrawn from the market, including the reasons for such action.

  • The Human Medicines Regulations 2012Law

    … Trials) Regulations 2004”. Article 13 (complaints, product recall and emergency unblinding) | The reference to “Article 123 of Directive 2001/83/EC” is to be read as a reference to “Part 5 of the Human Medicines Regulations 2012”.

  • The Human Medicines (Amendment) (No. 2) Regulations 2013Law

    … and 6 amend regulations 73, 113 and 142 of the 2012 Regulations respectively in order to transpose the changes made to articles 23a and 123 of Directive 2001/83/EC by Directive 2012/26/EU insofar as they apply to marketing authorisations, …

  • The Human Medicines (Amendment etc.) (EU Exit) Regulations 20191Law

    … Trials) Regulations 2004”. Article 13 (complaints, product recall and emergency unblinding) | The reference to “Article 123 of Directive 2001/83/EC” is to be read as a reference to “Part 5 of the Human Medicines Regulations 2012”.

  • Directive (EU) 2017/157213Law

    … изземване се извършва в съответствие с изискванията, посочени в член 123 от Директива 2001/83/ЕО.